José Francisco Kerr Saraiva

Universidade Estadual de Campinas (UNICAMP)

Also affiliated with Instituto de Medicina Avançada, Clinical Trial Investigators, Instituto Paulista de Ensino e Pesquisa, Agronomical Institute of Campinas, Pontifícia Universidade Católica de Campinas, Pontifícia Universidade Católica de São Paulo

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction”.

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

European Heart Journal(2021)10.1093/eurheartj/ehab499

N/A

4.2DataRank · unranked

154 citations

Pardeep S. Jhund, Inder S. Anand, Hans‐Dirk Düngen, Carolyn S.P. Lam, Marty Lefkowitz +15 more

Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.10.010

N/A

1.3DataRank · unranked

47 citations

Kristin M. Burns, Andrew C. Glatz, Christoph Male, Andrea Donti, Leonardo R. Brandão +27 more

Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00308-4

N/A

1.2DataRank · unranked

41 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer +14 more

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.4664

N/A

1.0DataRank · unranked

38 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Orly Vardeny +17 more

Finerenone According to Frailty in Heart Failure

JAMA Cardiology(2025)10.1001/jamacardio.2025.1775

N/A

0.693DataRank · unranked

14 citations

Pardeep S. Jhund, Alasdair D Henderson, Brian Claggett, Chern‐En Chiang, Gerard C.M. Linssen +18 more

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial

Cardiovascular Diabetology(2025)10.1186/s12933-025-02875-6

N/A

0DataRank · unranked

0 citations

Remo H.M. Furtado, Russell Esterline, Jan Oscarsson, Samvel B. Gasparyan, Gary G. Koch +18 more